Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 3, pp. 790-801
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 4, 2019
- Revision received October 25, 2019
- Accepted December 9, 2019
- Published first December 23, 2019.
Article Versions
- Previous version (December 23, 2019 - 07:23).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Silvana T. Tivadar1,
- Richard S. McIntosh1,
- Jia Xin Chua2,
- Robert Moss1,
- Tina Parsons2,
- Abed M. Zaitoun3,
- Srinivasan Madhusudan1,
- Lindy G. Durrant1,2,*, and
- Mireille Vankemmelbeke2
- 1Division of Cancer and Stem Cells, School of Medicine, City Hospital Campus, University of Nottingham, Nottingham, United Kingdom.
- 2Scancell Limited, University of Nottingham Biodiscovery Institute, Nottingham, United Kingdom.
- 3Section of Surgery, School of Medicine, Queens Medical Centre, University of Nottingham, Nottingham, United Kingdom.
- ↵*Corresponding Author:
Lindy G. Durrant, Scancell Limited, University of Nottingham Biodiscovery Insitute, University Park, Nottingham NG7 2RD, United Kingdom. Phone/Fax: 4411-5823-1863; E-mail: lindy.durrant{at}nottingham.ac.uk
March 2020
Volume 19, Issue 3
Volume 19, Issue 3
Monoclonal Antibody Targeting Sialyl-di-Lewisa–Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development Potential
Jump to section
Advertisement